Collagen biomarkers predict new onset of hypertension in normotensive participants: the Multi-Ethnic Study of Atherosclerosis

Objective: Vascular remodeling associated with increased extracellular matrix (ECM) may precede hypertension. Procollagen type III N-terminal propeptide (PIIINP) and collagen type I carboxy-terminal telopeptide (ICTP) reflect collagen turnover and are important in ECM remodeling. PIIINP and ICTP are increased in cardiovascular diseases (CVD). We hypothesized that PIIINP and ICTP among normotensives predict incident hypertension. Methods: We included 1252 Multi-Ethnic Study of Atherosclerosis participants with mean age 58.1 ± 12.4 years, 48% men, free of overt CVD, having SBP and DBP less than 130/85 mmHg and not using any antihypertensive medication, and having plasma PIIINP and ICTP measurements, all assessed at baseline. We studied the association of baseline PIIINP and ICTP with the relative incidence density (RID) of incident hypertension, defined as SBP/DBP at least 140/90 mmHg, or antihypertensive therapy use during follow-up (four examinations over median 9.4 years). Results: Baseline mean SBP/DBP was 110.9 ± 14.0/67.9 ± 10.4 mmHg. Mean concentration of PIIINP was 5.39 ± 1.95 &mgr;g/l and ICTP was 3.18 ± 1.39 &mgr;g/l. During follow-up visits, 35.9% of the participants developed hypertension. After adjustment for age, race, and sex there was a significant RID for new onset of hypertension of 1.16 (1.06, 1.28), P = 0.0017 for PIIINP and 1.20 (1.08,1.33) for ICTP, P = 0.0008. After additional adjustment for renal function, CVD risk factors and inflammatory variables, RID for new onset hypertension was 1.28 (1.15,1.42), P < 0.001 for PIIINP and 1.29 (1.15,1.44) for ICTP, P < 0.0001. Conclusion: Biomarkers of ECM remodeling predicted the development of hypertension in normotensive participants free of overt CVD.

[1]  D. Jacobs,et al.  Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis. , 2017, Clinical chemistry.

[2]  D. Jacobs,et al.  Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events. , 2016, Clinical chemistry.

[3]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[4]  D. Jacobs,et al.  High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis , 2015, Journal of the American Heart Association.

[5]  D. Wasserman,et al.  The extracellular matrix and insulin resistance , 2015, Trends in Endocrinology & Metabolism.

[6]  E. Rimm,et al.  Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study. , 2015, Atherosclerosis.

[7]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[8]  Valerie M. Weaver,et al.  The extracellular matrix at a glance , 2010, Journal of Cell Science.

[9]  F. Zannad,et al.  Extracellular matrix fibrotic markers in heart failure , 2010, Heart Failure Reviews.

[10]  Arantxa González,et al.  Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases , 2010, Circulation.

[11]  B. Pitt,et al.  Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study , 2009, Circulation.

[12]  D. Levy,et al.  Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community , 2009, Circulation.

[13]  H. Drexler,et al.  Endothelial function and hypertension , 2007, Current opinion in cardiology.

[14]  J. Cohn,et al.  Arterial stiffness as a risk factor for coronary atherosclerosis , 2007, Current atherosclerosis reports.

[15]  J. Cohn,et al.  Monitoring vascular health beyond blood pressure , 2006, Current hypertension reports.

[16]  S. Lai,et al.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. , 2006, AJR. American journal of roentgenology.

[17]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[18]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[19]  J. Díez,et al.  Abnormalities of the extracellular degradation of collagen type I in essential hypertension. , 1998, Circulation.

[20]  J. Díez,et al.  Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. , 1995, Circulation.

[21]  G. Di Candio,et al.  Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes , 2017, Hypertension.

[22]  Elizabeth Selvin,et al.  A comprehensive histopathological evaluation of vascular medial fibrosis: insights into the pathophysiology of arterial stiffening. , 2010, Atherosclerosis.

[23]  D. Bluemke,et al.  Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. , 2010, American journal of epidemiology.